Joseph Pantginis

Joseph Pantginis

Director of Research - Equity at H. C. Wainwright & Co. LLC

Finance
Consumer Services
Health Technology

Profile

Dr. Joseph Pantginis is a Director of Research & Managing Director of Equity Research at H.
C.
Wainwright & Co. LLC.
He has over 17 years of experience in healthcare equity research.
Prior to joining Rodman & Renshaw, Dr. Pantginis was most recently Senior Research Analyst and Head of Biotechnology Research at ROTH Capital Partners.
Prior positions included senior positions at Merriman, Canaccord Adams, Commerce Capital Markets, JBHanauer and Ladenburg.
Prior to his equity research career, he worked at Regeneron Pharmaceuticals, where he founded the Retroviral Core Facility.
Dr. Pantginis earned a Ph.D.
and M.S.
in molecular genetics from the Albert Einstein College of Medicine as well as an M.B.A.
from Pace University.

Joseph Pantginis active positions

CompaniesPositionStart
Director of Research - Equity -
All active positions of Joseph Pantginis

Former positions of Joseph Pantginis

CompaniesPositionEnd
Analyst-Equity 2017-05-31
Analyst-Equity 2016-11-30
Analyst-Equity 2009-11-29
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Joseph Pantginis's experience

Training of Joseph Pantginis

Pace University Masters Business Admin
Fordham University Undergraduate Degree
Albert Einstein College of Medicine, Inc. Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joseph Pantginis's experience

Connections

100 +

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
REGENERON PHARMACEUTICALS, INC.

Health Technology

Private companies9

Finance

Finance

Finance

Finance

First Albany Corp.

Finance

Finance

Finance

Finance

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Joseph Pantginis